Neuroimmune activation is a key feature of the pathologies of numerous psychiatric disorders including alcoholism, depression, and anxiety. Both HMGB1 and IL-1b have been implicated in brain disorders. Previous studies find HMGB1 andIL-1b form heterocomplexes in vitro with enhanced immune responses, lead to our hypothesis that HMGB1 and IL-1b heterocomplexes formed in vivo to contribute to the pathology of alcoholism. HMGB1/IL-1b heterocomplexes were prepared in vitro and found to potentiate IL-1b receptor proinflammatory gene induction compared to IL-1b alone in hippocampal brain slice culture. These HMGB1/IL-1b complexes were found to be increased in post-mortem human alcoholic hippocampus by co-immunoprecipiation. In mice, acute binge ethanol induced both HMGB1 and IL-1b in the brain and plasma. HMGB1 and IL-1b complexes were found only in mouse brain, with confocal microscopy revealing an ethanol-induced HMGB1 and IL-1b cytoplasmic co-localization. Surprisingly, IL-1b was found primarily in neurons. Studies in hippocampal brain slice culture found ethanol increased HMGB1/IL-1b complexes in the media. These studies suggest a novel neuroimmune mechanism in the pathology of alcoholism. Immunogenic HMGB1/IL-1b complexes represent a novel target for immune modulatory therapy in alcohol use disorders, and should be investigated in other psychiatric diseases that involve a neuroimmune component.
Introduction
Innate immune responses have been found to be important in the pathology of several psychiatric disorders such as alcoholism and depression (Hodes et al., 2015 , Crews, Lawrimore et al. 2017 . The release of endogenous Danger Associated Molecular Patterns (DAMPs) and cytokines amplify innate immune responses through signaling at Toll-like Receptors (TLRs) and cytokine receptors respectively. Alcohol abuse causes dysregulation of the innate immune system in part through the release of endogenous TLR agonists (Crews and Vetreno, 2016, Crews, Lawrimore et al. 2017) . The induction of the DAMP HMGB1 is a key feature of the immune activity of alcohol. HMGB1 is induced in the brain by chronic alcohol in vitro and is also increased in the brain of postmortem human alcoholics (Crews et al., 2013 , Lippai et al., 2013 , Coleman and Zou, 2017 . HMGB1 is a nuclear histone-binding protein that has been described as a master regulator of innate immunity (Castiglioni, Canti et al. 2011) . Upon activation, HMGB1 translocates from the nucleus and is released, where it directly binds immune receptors TLR4 and RAGE, and facilitates the signaling of an array of other TLRs including TLR2, TLR3, TLR7 and TLR9 (Hori et al., 1995 , Yanai et al., 2009 , Coleman and Zou, 2017 . Furthermore, HMGB1 has been shown to form complexes with immune molecules such as LPS, CXCL12, and IL-1b in vitro to potentiate their responses (Bianchi 2009 , Hreggvidsdottir et al., 2009 , Schiraldi et al., 2012 . Thus, HMGB1 not only modulates innate immune responses through its own activity, but by modulating responses of other immune agonists' receptor signaling.
HMGB1 signaling is often linked with the release of the proinflammatory cytokine IL-1b. Both HMGB1 and IL-1b amplify immune responses and contribute to aberrant inflammation (Keyel 2014). IL-1b has also been implicated in the pathology of alcohol abuse. IL-1b mRNA levels are increased in the peripheral monocytes of alcoholics and correlate with alcohol consumption and craving (Leclercq et al., 2014) . Chronic alcohol increases IL1b in the cerebellum (Lippai et al., 2013) and IL-1b antagonism in the basolateral amygdala reduces alcohol self-administration (Marshall et al., 2016) . Both HMGB1 and IL-1b release has been shown to utilize unconventional secretion mechanisms, due to their lack of conventional secretory leader sequence (Gardella et al., 2002; Nickel and Rabouille, 2009) . However, it is not known whether HMGB1 and IL-1b are released together. HMGB1 and IL-b have been shown to form complexes in vitro (Sha et al., 2008 , Hreggvidsdottir et al., 2009 , but this has not been shown
